
SHAREHOLDER INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation Of Douglas Elliman Inc. (NYSE: DOUG) And Encourages Investors To Contact The Firm
PHILADELPHIA, Dec. 20, 2024 /PRNewswire/ -- Kaskela Law LLC announces that it has commenced an investigation into Douglas Elliman Inc. (NYSE: DOUG ) on behalf of the company's shareholders.
Click here for additional information:
Since January 2022, shares of Douglas Elliman's stock have declined in value from a trading price of over $10.00 per share to a current trading price of less than $2.00 per share, a decline of over 80% in value .
The investigation seeks to determine whether Douglas Elliman and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's shareholders in connection with recent corporate actions.
Douglas Elliman
shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options.
Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected] )
Adrienne Bell, Esq.
([email protected] )
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE Kaskela Law LLC
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment